Prograf 0.5 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DR26FHY3N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,999
Award facts
- Contract value 100% obligated
- $3,999.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,999.03 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 0.5 mg on October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and runs through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support defense health programs. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and certain autoimmune conditions, reflecting the breadth of specialty pharmaceutical products the contractor provides to federal healthcare customers. The DLA's Pharmaceutical Prime Vendor Global Program is planning to establish Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key supplier within this strategic procurement initiative.
Quick answers
Who was awarded contract SPE2DR26FHY3N?
SPE2DR26FHY3N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FHY3N worth?
The government has obligated $3,999 on SPE2DR26FHY3N.
Is contract SPE2DR26FHY3N an order under another contract?
Yes. SPE2DR26FHY3N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY3N competed?
The extent of competition for SPE2DR26FHY3N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award